RxDoctor Payments Data

Andrea McKay, APRN

Family · Centerville, OHNPI 1376039388

Payments from drug & device makers

$1,162in general payments, 2019–2025

Across 69 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$326
  • EMD Serono, Inc.$157
  • Lilly USA, LLC$101
  • SK Life Science, Inc.$73
  • Novartis$67
  • MDD US Operations, LLC$62
  • plus $376 from 14 others

What the payments were for

  • Food & beverage$1,162100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,162 in reported general payments places this provider in the 70th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$39,029
Medicare patients
305
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine22$190,317
IngrezzaValbenazine Tosylate15$128,287
UbrelvyUbrogepant112$126,088
NuplazidPimavanserin Tartrate21$111,895
Nurtec OdtRimegepant Sulfate76$82,765
QuliptaAtogepant46$52,873
Aimovig AutoinjectorErenumab-Aooe54$42,512
Emgality PenGalcanezumab-Gnlm53$40,322
BriviactBrivaracetam27$35,703
RytaryCarbidopa/Levodopa17$25,774
Lacosamide166$22,763
GocovriAmantadine Hcl13$21,877
Memantine Hcl552$18,686
Levetiracetam548$14,901
Ajovy AutoinjectorFremanezumab-Vfrm19$14,389

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$326$178,962158 claims
Neurocrine Biosciences, Inc.Ingrezza$28$128,28715 claims
Acadia Pharmaceuticals IncNuplazid$16$111,89521 claims
Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide$13$27,27034 claims
MDD US Operations, LLCGocovri$62$21,87713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,812 family providers in Ohio.

Other family in Centerville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →